Puberty blockers have been recommended for over two decades. Initial guidelines for the use of puberty blockers in adolescents were developed in the mid-1990s, and since then have been introduced into international guidance by prominent medical institutions like the World Professional Association for Transgender Health and the Endocrine Society.
The use of puberty blockers has thus been a standard part of medical care for many years. Although some countries, like the UK, do not always follow the most up-to-date guidance, GenderGP is proud to provide care in line with the global standard.
You can find more information about puberty blockers on our website.